Abstrait

Moving Toward Drug Development for Ebola Virus Disease Based on Structure

Elen Sukan

The Ebola Virus Disease (EVD) is a highly lethal viral infection with a significant global health impact. Despite the recent advancements in understanding the molecular and structural biology of the Ebola virus, there is still no specific and widely approved antiviral treatment. This article explores the potential of structural-based drug development strategies for combating Ebola virus disease. Utilizing structural information about the virus and its key proteins can guide the rational design of novel drugs, offering new avenues for therapeutic interventions.